4 Firms Shape Biosimilar Biz Alvotech's $2.3B SPAC Deal
Cooley LLP-led Icelandic drugmaker Alvotech said Tuesday it plans to merge with Oaktree Acquisition Corp. II, a special purpose acquisition company guided by Kirkland & Ellis LLP and King & Spalding...To view the full article, register now.
Already a subscriber? Click here to view full article